In conclusion, our data provides compelling evidence that combination treatment is effective against MDA-MB-231 TNBC cells as well as tumor xenografts by inactivation of NF-κB, induction of apoptosis and inhibition of angiogenesis. This evidence concerns the gene NFKB1 and neoplasm.